Comparison of upper extremity versus lower extremity vein injections of bubble contrast in assessment of patent foramen ovale


Creative Commons License

Mutlu D., Durmaz E., Karpuz M. H., Karadağ B., İkitimur B., Koca D., ...Daha Fazla

European Society of Cardiology Congress 2020, Amsterdam, Hollanda, 29 Ağustos - 01 Eylül 2020, cilt.41, sa.946, ss.2430, (Özet Bildiri)

  • Yayın Türü: Bildiri / Özet Bildiri
  • Cilt numarası: 41
  • Doi Numarası: 10.1093/ehjci/ehaa946.2430
  • Basıldığı Şehir: Amsterdam
  • Basıldığı Ülke: Hollanda
  • Sayfa Sayıları: ss.2430
  • İstanbul Üniversitesi-Cerrahpaşa Adresli: Evet

Özet

Background: Patent foramen ovale (PFO) is one of the causes of cardioembolism

and closure of PFO is recommended by the current guidelines

in patients with recurrent stroke. Transoesophageal echocardiography

(TEE) using bubble-contrast study is the gold standard imaging modality for

the assessment of interatrial septum. Upper-extremity veins are the most

common way of injection, however, the presence of Eustachian valve and

flow dynamics when bubble-contrast injection performed via upper extremity

veins limits the assessment of interatrial septum in several cases. In this

study, we aimed to compare the efficacy of bubble-contrast study between

upper extremity injection and lower extremity injection.

Material/Methods: Patients with a suspicion of cardioembolism who were

undergoing TEE study were included in this study. After routine assessment

of cardiac structures, the bubble-contrast study was performed using

agitated saline from both upper-extremity vein and lower-extremity vein

with Valsalva manoeuvre. Right-to-left shunt and numbers of bubbles transmitted

from the septum were recorded.

Results: We prospectively included 45 patients and 21 PFOs were detected.

There were 9 patients with prominent Eustachian valve and in 6

patients Eustachian valve hampered the complete opacification of the right

atrium. In 3 patients flow from the superior vena cava was directed towards

the tricuspid valve and hampered the complete opacification. Among

21 patients with PFO, in 6 patients right-to-left shunt was not observed

when agitated-saline was injected via the upper-extremity vein, however,

the shunt was observed when the agitated-saline was injected via the

lower-extremity vein. In 14 patients amount of bubbles passing through

the interatrial septum were significantly higher when the injection was performed

via the lower-extremity vein especially in patients with prominent

Eustachian valve.

Conclusion: Our preliminary results indicated that compared to upperextremity

veins, injection via the lower-extremity veins provides better

opacification of right atrial septum and assessment of interatrial septum.

Therefore, injection through the lower-extremity veins would be the preferred

choice particularly in patients with prominent Eustachian valve or

downward directed flow from the superior vena cava.